2-deoxycoformycin in the treatment of T-large granular lymphocyte leukemia

Leuk Res. 2003 Sep;27(9):865-7. doi: 10.1016/s0145-2126(03)00019-5.

Abstract

A 52-year-old woman presented to our clinic for investigation of agranulocytosis and mild lymphocytosis. A diagnosis of T-large granular lymphocyte leukemia was made, based on immunophenotyping findings of the peripheral blood lymphocytes (CD3, CD8, CD16, CD57). Flow cytometric analysis of TCR-Vbeta repertoire showed single Vbeta9 expression on peripheral T-cells. Clonality was also demonstrated with PCR analysis which revealed clonal rearrangement of TCRgamma-chain gene. Granulocyte-macrophage colony-stimulating factor (G-CSF) (G-CSF), cyclosporine, methylprednisolone and oral methotrexate failed to correct the neutropenia. Finally, treatment with 2-deoxycoformycin (DCF) was successful and resulted in complete correction of the neutrophil count. Flow cytometric analysis of TCR-Vbeta repertoire proved to be an effective method to assess the therapeutic response to various treatments and to evaluate residual disease.

Publication types

  • Case Reports

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use*
  • Antigens, CD / metabolism
  • Female
  • Flow Cytometry
  • Genes, T-Cell Receptor beta / physiology
  • Humans
  • Immunoglobulin Variable Region / immunology*
  • Immunophenotyping
  • Leukemia, Lymphoid / drug therapy*
  • Leukemia, Lymphoid / genetics
  • Leukemia, Lymphoid / immunology
  • Leukemia, T-Cell / drug therapy*
  • Leukemia, T-Cell / genetics
  • Leukemia, T-Cell / immunology
  • Middle Aged
  • Neutropenia / blood
  • Neutropenia / complications
  • Neutropenia / drug therapy
  • Pentostatin / therapeutic use*
  • Remission Induction

Substances

  • Antibiotics, Antineoplastic
  • Antigens, CD
  • Immunoglobulin Variable Region
  • Pentostatin